Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity
Massachusetts Institute of Technology · Alnylam Pharmaceuticals (United States)
Indexed incrossrefdoajpubmed
Abstract
No abstract available for this paper.
Citation impact
615
total citations
- FWCI
- 16.22
- Percentile
- 100%
- References
- 44
Citations per year
Authors
16Topics & keywords
Topics
Keywords
- In vivo
- Gene knockdown
- RNA interference
- Gene silencing
- Transfection
- Small interfering RNA
- In vitro
- Chemistry
No related works found for this paper.